(RTTNews) - Protara Therapeutics, Inc. (TARA) announced Friday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on a registrational path forward for intravenous (IV ...

Protara Therapeutics Announces Fast Track Designation For Intravenous Choline Chloride October 21, 2024 — 08:31 am EDT Written by RTTNews.com for RTTNews -> ...

In previous studies, treatment with IV Choline Chloride successfully increased plasma choline concentrations in patients on PN and was also shown to improve steatosis, a key marker of liver injury.

Protara Therapeutics. New development pathway significantly expands addressable patient population for IV Choline Chloride. IV Choline Chloride has the potential to become the first FDA-approved ...